Should I buy or sell Life Science REIT stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Life Science REIT in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LABS shares. View LABS analyst ratings or view top-rated stocks .

What is Life Science REIT's stock price target for 2024?

1 analysts have issued 12-month price targets for Life Science REIT's stock. Their LABS share price targets range from GBX 79 to GBX 79. On average, they anticipate the company's share price to reach GBX 79 in the next twelve months. This suggests a possible upside of 103.1% from the stock's current price. View analysts price targets for LABS or view top-rated stocks among Wall Street analysts .

How have LABS shares performed in 2024?

Life Science REIT's stock was trading at GBX 63.20 at the beginning of 2024. Since then, LABS stock has decreased by 38.4% and is now trading at GBX 38.90. View the best growth stocks for 2024 here .

How often does Life Science REIT pay dividends? What is the dividend yield for Life Science REIT?

Life Science REIT announced a dividend on Tuesday, March 26th. Stockholders of record on Thursday, April 4th will be given a dividend of GBX 1 per share on Monday, May 13th. This represents a dividend yield of 2.32%. The ex-dividend date of this dividend is Thursday, April 4th. The official announcement can be accessed at this link . Read our dividend analysis for LABS .

Is Life Science REIT a good dividend stock?

Life Science REIT (LON:LABS) pays an annual dividend of GBX 4 per share and currently has a dividend yield of 7.09%. LABS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for LABS .

How do I buy shares of Life Science REIT?

Shares of LABS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:LABS

Life Science REIT (LABS) Share Price, News & Analysis

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)

Free LABS Stock Alerts

GBX 38.90

+0.30 (+0.78%)

(As of 04/25/2024 ET)

Today's Range: 38.60
▼
39.90
50-Day Range: 37.10
▼
48.90
52-Week Range: 37.10
▼
77.40

Volume: 255,249 shs
Average Volume: 899,607 shs
Market Capitalization: £136.15 million

P/E Ratio: N/A
Dividend Yield: 10.28%
Price Target: GBX 79

Stock Analysis Analyst Forecasts Chart Dividend

Get Life Science REIT alerts:

Ad Prosper Trading Academy

These AI trades triggered this morning (545% return)

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

About Life Science REIT

LABS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LABS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive LABS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Life Science REIT and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/13 Dividend: 4/04/2024
Today: 4/25/2024
Dividend Payable: 5/13/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: LON:LABS
CUSIP: N/A
CIK: N/A
Web: www.lifesciencereit.co.uk
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: GBX 79
High Stock Price Target: GBX 79
Low Stock Price Target: GBX 79
Potential Upside/Downside: +102.2%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX (0.08)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-29,190,000.00
Net Margins: -151.24%
Pretax Margin: N/A
Return on Equity: -8.24%
Return on Assets: 0.82%

Debt

Debt-to-Equity Ratio: 31.91
Current Ratio: 1.35
Quick Ratio: N/A

Sales & Book Value

Annual Sales: £19.30 million
Price / Sales: 7.09
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: GBX 90 per share
Price / Book: 0.43

Miscellaneous

Outstanding Shares: 350,000,000
Free Float: N/A
Market Cap: £136.76 million
Optionable: Not Optionable
Beta: 0.20

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Dr. Sally Ann Forsyth O.B.E.
Ph.D., Independent Non-Exec. Director & Sustainability Lead
Mr. Simon Farnsworth (Age 56)
Managing Director of Ironstone Asset Management Limited
Mr. David Lewis
Director of Operations & Fin. of Ironstone Asset Management Limited
Ms. Joanna Waddingham
Head of Investor Relations & Corp. Affairs of Ironstone Asset Management Limited
Ms. Stephanie Adams
Legal Counsel of Ironstone Asset Management Limited
Mr. Ian Harris
Director of Asset Management of Ironstone Asset Management Limited
Ms. Pippa Stacey
Head of ESG & Consultant of Ironstone Asset Management Limited
Tamara Deering
Head of Financial Planning & Reporting of Ironstone Asset Management Limited
Mr. Daniel Williams
Corp. & Devel. Financial Controller - Ironstone Asset Management Limited

LABS Stock Analysis - Frequently Asked Questions

Should I buy or sell Life Science REIT stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Life Science REIT in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LABS shares.
View LABS analyst ratings or view top-rated stocks.
What is Life Science REIT's stock price target for 2024?: 1 analysts have issued 12-month price targets for Life Science REIT's stock. Their LABS share price targets range from GBX 79 to GBX 79. On average, they anticipate the company's share price to reach GBX 79 in the next twelve months. This suggests a possible upside of 103.1% from the stock's current price.
View analysts price targets for LABS or view top-rated stocks among Wall Street analysts.
How have LABS shares performed in 2024?: Life Science REIT's stock was trading at GBX 63.20 at the beginning of 2024. Since then, LABS stock has decreased by 38.4% and is now trading at GBX 38.90.
View the best growth stocks for 2024 here.
How often does Life Science REIT pay dividends? What is the dividend yield for Life Science REIT?: Life Science REIT announced a dividend on Tuesday, March 26th. Stockholders of record on Thursday, April 4th will be given a dividend of GBX 1 per share on Monday, May 13th. This represents a dividend yield of 2.32%. The ex-dividend date of this dividend is Thursday, April 4th. The official announcement can be accessed at this link.
Read our dividend analysis for LABS.

Is Life Science REIT a good dividend stock?: Life Science REIT (LON:LABS) pays an annual dividend of GBX 4 per share and currently has a dividend yield of 7.09%. LABS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for LABS.
How do I buy shares of Life Science REIT?: Shares of LABS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:LABS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial